Pituitary Irradiation for Breast Cancer
Author Information
Author(s): W. P. Greening, G. S. Ramsay, J. J. Stevenson, E. Boyland, P. C. Rigby-Jones, B. Godsmark
Primary Institution: Royal Marsden Hospital
Hypothesis
Can interstitial irradiation of the pituitary improve outcomes in patients with advanced breast cancer?
Conclusion
The study found that interstitial irradiation of the pituitary had a low remission rate and significant complications, but may still be useful in certain cases.
Supporting Evidence
- Only two patients are alive after treatment, with a low overall remission rate of 12%.
- The average survival after treatment was 19.4 months.
- Complications included headache, diabetes insipidus, and meningitis, leading to 10 deaths.
Takeaway
Doctors tried a new way to treat breast cancer by using radiation on the pituitary gland, but it didn't help most patients and caused some serious problems.
Methodology
Patients with advanced breast cancer were treated with either gold-198 or yttrium-90 isotopes implanted in the pituitary gland.
Potential Biases
Selection bias may exist as only patients who had failed previous treatments were included.
Limitations
The study included patients who had already undergone other treatments, making it difficult to assess the effectiveness of this method alone.
Participant Demographics
Patients with advanced breast cancer, previously treated with other methods.
Want to read the original?
Access the complete publication on the publisher's website